Therepeutic Emesis And Therepeutic Purgation In The Managment Of Psoriasis
Phase 2
Completed
- Conditions
- Health Condition 1: null- patient suffering from classical symptom of mandal kushthaHealth Condition 2: L409- Psoriasis, unspecified
- Registration Number
- CTRI/2018/02/012093
- Lead Sponsor
- ational Institute Of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1.Patients between 16 and 60 years of age
2.Patients with the clinical features of Mandal kushtha (psoriasis)
3.Patients fit for Vamana and Virechana.
Exclusion Criteria
1.Patients aged below 16 and above 60 years.
2.Patients with Tuberculosis, Leprosy, Paralysis and malignant disease.
3.Pregnant women and lactating mother
4.Patients with severe systemic disorders as Uncontrolled Hypertension, Cardiac Problem Diabetes Mellitus etc
5.Patients unfit for Vamana and Virechana
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Subjective and objective parameterTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method To Find out the comparative efficacy of the treatment in different groupsTimepoint: 6 month